According to Krystal Biotech's latest financial reports the company has a price-to-book ratio of 5.85.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 4.49 | 15.06% |
2022-12-31 | 3.91 | 33.07% |
2021-12-31 | 2.94 | -27.52% |
2020-12-31 | 4.05 | -14.5% |
2019-12-31 | 4.74 | 78.86% |
2018-12-31 | 2.65 | 21.65% |
2017-12-31 | 2.18 | |
2016-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.81 | -51.99% | ๐บ๐ธ USA |